Alison Moskowitz
9PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.Pallawi Torka, Tatyana Feldman, Kerry J Savage
|Feb 02, 2024
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs).Alison J Moskowitz, Robert N Stuver, Steven M Horwitz
|Sep 18, 2023
Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma.Julia Driessen, Gerben J C Zwezerijnen, Heiko Schöder
|Jun 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.Alison J Moskowitz, Gunjan Shah, Heiko Schöder
Pageof 2
Frequent Collaborators
5 joint publications
Steven M Horwitz
4 joint publications
Andrew D Zelenetz
4 joint publications
Heiko Schöder
4 joint publications
Maria Lia Palomba
3 joint publications
Joachim Yahalom
3 joint publications
Connie L Batlevi
3 joint publications
Esther Drill
3 joint publications
Matthew J Matasar
3 joint publications
Anita Kumar
2 joint publications
Erel Joffe